Market news

UFP Technologies has seen a powerful run in its share price in recent years, which naturally raises a question for anyone looking at the stock today. Is the current valuation supported by the company’s earnings, or has sentiment moved ahead of the underlying profit stream? Over the past 5 years, UFP Technologies has delivered a total return of about 3.8x, which puts real pressure on the current earnings multiple to carry that track record forward. The business leans heavily on specialized...

Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the letter here. The Tributary Multi Cap Core’s equity allocation underperformed in Q2, returning +12.5% against +15.3% for the S&P 1500 and +15.4% for the Russell 3000. Information Technology was the main driver of […]

Detailed price information for Cintas Corp (CTAS-Q) from The Globe and Mail including charting and trades.

Veracyte, Globus Medical and UFP Technologies are positioned to benefit as GenAI adoption reshapes medical instruments.

Investors need to pay close attention to UFPT stock based on the movements in the options market lately.

On August 3, UFP Technologies (NASDAQ:UFPT) reported second-quarter net income of $20.9 million, up 21.4% from $17.2 million a year earlier, alongside net sales of $174.0 million, a 15.1% jump from $151.2 million. Both figures, along with adjusted earnings per share of $2.92, marked the best quarter in the company’s history. For the six months […]

Feldmann reduced her direct stake by 18%.

UFP Technologies (NASDAQ:UFPT) outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies. President and Chief Executive Officer Mitch Rock said the company provides engineer

Detailed price information for Exlservice Holdings (EXLS-Q) from The Globe and Mail including charting and trades.

NEWBURYPORT, Mass., August 20, 2026--UFP Technologies, Inc. (Nasdaq: UFPT), today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1-on-1 meetings at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 at The InterContinental in Chicago, IL. The company’s presentation is scheduled to begin at 8:35 AM CT. The presentation is webcast and can be accessed through the conf

Cynthia L Feldmann, Director, on August 13, 2026, sold 1,000 shares in Ufp Technologies (UFPT) for $

UFP Technologies delivered a calendar second quarter marked by strong, broad-based growth across its MedTech platform, which exceeded Wall Street’s revenue and profit expectations. Management pointed to robust performance in key submarkets such as cardiovascular, infection control, and orthopedics, as well as continued diversification across customer programs. CEO Mitchell Rock, in his first earnings call as chief executive, emphasized that growth this quarter was not tied to any one customer or

Disclosed on August 10, R. Jeffrey Bailly, Executive Chairman at UFP Technologies (NASDAQ:UFPT), executed a substantial insider sell as per the latest SEC filing. What Happened: According to a Form 4 filing with the

R Jeffrey Bailly, Director, Executive Chairman, on August 06, 2026, sold 15,695 shares in UFP Techno

R Jeffrey Bailly, Director, Executive Chairman, on August 10, 2026, sold 13,011 shares in Ufp Techno

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

Jason Holt, Vice President, on August 06, 2026, sold 1,100 shares in Ufp Technologies (UFPT) for $34

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

UFP Technologies (UFPT) is back in focus after reporting record Q2 2026 results, with sales of $173.96 million and net income of $20.85 million. Both figures were above the prior year’s levels. See our latest analysis for UFP Technologies. The strong Q2 2026 earnings have come alongside a clear pickup in momentum for UFP Technologies, with a 22.61% 90 day share price return and a 19.75% year to date share price return, while the 5 year total shareholder return of 319.98% points to substantial...

UFP Technologies easily surpassed Wall Street's expectations and continued to deliver double-digit sales growth.

UFP Technologies easily surpassed Wall Street's expectations and continued to deliver double-digit sales growth.

UFP Technologies (NASDAQ:UFPT) reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8% to a company-record $2.92. President and Chief Executive Officer Mitch Rock, speak

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

UFP Technologies (NASDAQ:UFPT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our

Moby summary of UFP Technologies, Inc.'s Q2 2026 earnings call

UFP (UFPT) delivered earnings and revenue surprises of +16.34% and +8.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

NEWBURYPORT, Mass., August 03, 2026--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1%

UFP Technologies (UFPT) reported Monday Q2 adjusted earnings of $2.92 per diluted share, up from $2.

Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting results this Monday after market hours. Here’s what you need to know.

Detailed price information for U F P Tech Inc (UFPT-Q) from The Globe and Mail including charting and trades.

NEWBURYPORT, Mass., July 29, 2026--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the second quarter on Monday, August 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, August 4th, at